Press release
Global Breast Cancer Monoclonal Antibodies Market to post a revenue of 13.7 billion by 2020
About Breast Cancer mAbsBreast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protein stimulates the growth and division of malignant cells. Antibodies are the proteins produced by B-cells (in the bone marrow) in the immune system. These proteins attach themselves to antigens, which act as markers, and are then destroyed by phagocytes. B-cells produce different antibodies, which attach themselves to different sites of an antigen. mAbs are monospecific, as they are the clones of a single parent cell.
Technavios analysts forecast the global breast cancer monoclonal antibodies (mAbs) market to post a revenue of 13.7 billion by 2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global breast cancer monoclonal antibodies (mAbs) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of branded mAbs and biosimilars used to treat breast cancer.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Breast Cancer Monoclonal Antibodies (mAbs) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Download Sample copy of Report at http://www.marketresearchreports.biz/sample/sample/816220
Key vendors
Amgen
Roche
Mylan
Other prominent vendors
Array BioPharma
AstraZeneca
Biocad
Boehringer Ingelheim
Bristol-Myers Squibb
Celldex Therapeutics
Celltrion
Chugai Pharmaceutical
Daiichi Sankyo
DARA Biosciences
Eddingpharm
Eisai
Galena Biopharma
GlaxoSmithKline
Halozyme Therapeutics
Hospira
ImmunoGen
Immunomedics
MacroGenics
Merck
Novartis
Oncothyreon
Pfizer
ProStrakan
Puma Biotechnology
Seattle Genetics
Sun Pharmaceutical Industries
Synta Pharmaceuticals
Teva Pharmaceuticals
Market driver
Reimbursement benefits for breast cancer mAbs
For a full, detailed list, view our report
Market challenge
Absence of adequate diagnosis and screening procedures for early detection
For a full, detailed list, view our report
Market trend
Emergence of targeted and combination therapies for breast cancer
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Breast Cancer Monoclonal Antibodies Market to post a revenue of 13.7 billion by 2020 here
News-ID: 392613 • Views: …
More Releases from Medical Research Report
Genomic Health Inc (GHDX) - Product Pipeline Analysis: Size, Share, Growth, Tren …
“Genomic Health Inc Product Pipeline” is a provider of genomic-based clinical laboratory services for the treatment of cancer. The companys commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, and Onco type DX prostate cancer test. It perform extensive research and development activities to optimize the treatment of urologic cancers including prostate, bladder, and kidney cancers, and additional treatment decisions in breast and…
Foundation for Innovative New Diagnostics - Product Pipeline Analysis: Size, Sha …
Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured project management framework, product development services, buruli ulcer diagnosis, chagas disease diagnostic solutions, hat diagnostic solutions, and tuberclosis diagnostic solutions. FIND also provides malaria therapy programs, neglected tropical diseases therapy programs, tuberculosis therapy programs, HIV…
Exalenz Bioscience Ltd (EXEN) - Product Pipeline Analysis : Size, Share, Growth, …
Exalenz Bioscience Ltd (Exalenz) carries out the development and commercialization of advanced medical systems for a range of gastrointestinal (GI) tract and liver disorders. The company harnesses its BreathID technology platform for assessment and monitoring of functional diseases. Its flagship product, BreathID Hp is a urea breath test for diagnosing, monitoring and managing gastric Helicobacter pylori (H. pylori) infection in adults. The BreathID Hp is US Food and Drug Administration…
United States Next Generation Cancer Diagnostics Market: Size, Growth Factors an …
A latest research report titled as ”United States Next Generation Cancer Diagnostics Market: Size, Growth Factors and Industry Forecast 2022” has been recently added to the vast portfolio of Market Research Hub (MRH) online research offerings. This report is a professional and in-depth analysis on the present state and future prospect for the global market. It provides valuable information to the industry insiders, potential entrants or investors. It includes an…
More Releases for Pharmaceutical
Metronidazole Market 2023 Latest Innovations and Outlook By Players - Hongyuan P …
The Metronidazole Market 2023 study focuses on a global evaluation of information from the most recent market developments. The purpose of MarketsandResearch.biz is to offer the company's customers a comprehensive market overview to formulate development plans.
Designing of the report is done with the help of infographics, charts, and graphs. The report initially analyzes the various segments of the global Metronidazole market in a brief manner, which includes product types, applications.…
Hyperthyroidism Treatment Market Analytical Overview and Future | Merck, Herbran …
The Hyperthyroidism Treatment market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with development…
Mevastatin Market Is Booming Worldwide |Zhejiang Hisun Pharmaceutical, Guangdong …
Global Mevastatin Market Size research report 2022 offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. This study provides information about the sales and revenue during the historic and forecasted period of (2022 to 2028). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for…
Global Specialty Pharmaceutical Market Driving Future Growth on Specialty Pharma …
Global Specialty Pharmaceutical Industry Synopsis:
The Specialty Pharmaceutical Market report provides a detailed analysis of this business space. The market is analyzed in terms of production as well as consumption. Based on the production aspect, the report includes particulars pertaining to the manufacturing processes of the product, alongside revenue and gross margins of the respective manufacturers.
The Global Specialty Pharmaceutical Market will reach xxx Million USD in 2020 with CAGR xx%…
Metronidazole Market to 2023 (+5% CAGR Expected) Top Player Profiles – Hongyua …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in…
Metronidazole Market by Top Key Participant Hongyuan Pharmaceutical, Yinhe Aarti …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.researchbeam.com/global-metronidazole-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/request-sample?utm_source=Anil
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in North…
